300 related articles for article (PubMed ID: 11751033)
1. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
[TBL] [Abstract][Full Text] [Related]
2. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Panayi F; Colussi-Mas J; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
[TBL] [Abstract][Full Text] [Related]
3. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization.
Horger BA; Taylor JR; Elsworth JD; Roth RH
Neuropsychopharmacology; 1994 Nov; 11(3):215-22. PubMed ID: 7865101
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
Rompré P; Perron S
Neuropharmacology; 2000 Jul; 39(10):1880-92. PubMed ID: 10884569
[TBL] [Abstract][Full Text] [Related]
5. Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability.
Costa FG; Frussa-Filho R; Canteras NS; Valera AG; Felicio LF
Neuropeptides; 2007 Apr; 41(2):83-91. PubMed ID: 17276509
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine.
Betancur C; Cabrera R; de Kloet ER; Pélaprat D; Rostène W
Neuropsychopharmacology; 1998 Oct; 19(4):322-32. PubMed ID: 9718595
[TBL] [Abstract][Full Text] [Related]
7. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice.
Costa FG; Frussa-Filho R; Felicio LF
Eur J Pharmacol; 2001 Sep; 428(1):97-103. PubMed ID: 11779043
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.
Felszeghy K; Espinosa JM; Scarna H; Bérod A; Rostène W; Pélaprat D
Neuropsychopharmacology; 2007 Dec; 32(12):2601-10. PubMed ID: 17356568
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.
Salomon L; Lanteri C; Godeheu G; Blanc G; Gingrich J; Tassin JP
Psychopharmacology (Berl); 2007 Sep; 194(1):11-20. PubMed ID: 17510759
[TBL] [Abstract][Full Text] [Related]
10. Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
Casti P; Marchese G; Casu G; Ruiu S; Pani L
Neuropharmacology; 2004 Jul; 47(1):128-35. PubMed ID: 15165840
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
[TBL] [Abstract][Full Text] [Related]
13. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.
Chiang YC; Chen PC; Chen JC
Brain Res; 2003 May; 972(1-2):159-67. PubMed ID: 12711089
[TBL] [Abstract][Full Text] [Related]
14. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
15. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic ICV leptin infusion on motor-activating effects of D-amphetamine in food-restricted and ad libitum fed rats.
Hao J; Cabeza de Vaca S; Carr KD
Physiol Behav; 2004 Dec; 83(3):377-81. PubMed ID: 15581659
[TBL] [Abstract][Full Text] [Related]
17. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
Bauco P; Rompré PP
Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Feldpausch DL; Needham LM; Stone MP; Althaus JS; Yamamoto BK; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):497-508. PubMed ID: 9655895
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to amphetamine psychostimulant effect: A key role for ventral tegmental area neurotensin type 2 receptors and MAP kinase pathway.
Voyer D; Einsiedel J; Gmeiner P; Lévesque D; Rompré PP
Addict Biol; 2021 Sep; 26(5):e13008. PubMed ID: 33491227
[TBL] [Abstract][Full Text] [Related]
20. Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis.
Colussi-Mas J; Panayi F; Scarna H; Renaud B; Bérod A; Lambás-Señas L
Int J Neuropsychopharmacol; 2005 Dec; 8(4):569-81. PubMed ID: 15836801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
